[Mary Zawadzki]

Libtayo® (cemiplimab) is now publicly covered in all provinces except Prince Edward Island (PEI) for patients with Metastatic Cutaneous Squamous Cell Carcinoma (cSCC): https://www.melanomanetwork.ca/cscchome/cemiplimab/

[Author]

Posts